The Ig heavy chain 3' end confers a posttranscriptional processing advantage to Bcl-2-IgH fusion RNA in t(14;18) lymphoma

Blood

Volumn 91, Issue 10, 1998, Pages 3952-3961

  Petrovic, Alexander Scheidel ^b   Young, Robert L ^b   Hilgarth, Bernadette ^b   Ambros, Peter ^b   Korsmeyer, Stanley J ^b   Jaeger, Ulrich ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; RNA;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CHROMOSOME 14Q; CHROMOSOME 18Q; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; GENE CONTROL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTO ONCOGENE;

EID: 0032525112     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.10.3952.3952_3952_3961     Document Type: Article

References (68)

1. Tsujimoto Y, Gorham J, Crossman J, Jaffe E, Croce CM: The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229:1390, 1985
2. Bakhshi AJ, Jensen JP, Goldman P, Wright JJ, McBride OW, Epstein AL, Korsmeyer SJ: Cloning the chromosomal breakpoint of t(14;18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41:899, 1985
3. Cleary ML, Sklar J: Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82:4739, 1985
4. Cleary ML, Smith SD, Sklar J: Cloning and structural analysis of cDNAs for Bcl-2 and a hybrid Bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47:19, 1986
5. Graninger WB, Seto M, Boutain B, Goldman P, Korsmeyer SJ: Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells. J Clin Invest 80:1512, 1987
6. Seto M, Jaeger U, Hockett RD, Graninger W, Bennett S, Goldman P, Korsmeyer SJ: Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma. EMBO J 7:123, 1988
7. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP, Korsmeyer SJ: Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57:79, 1989
8. McDonnell TJ, Korsmeyer SJ: Progression from lymphoid hyperplasia to high grade malignant lymphoma in mice transgenic for the t(14;18). Nature 349:254, 1991
9. Cleary ML, Galili N, Sklar J: Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas. J Exp Med 164:315, 1986
10. Silverman GA, Green ED, Young RL, Jockel JI, Domer PH, Korsmeyer SJ: Meiotic recombination between yeast artificial chromosomes yields a single clone containing the entire Bcl-2 proto-oncogene. Proc Natl Acad Sci USA 87:9913, 1990
11. Reed JC, Tsujimoto Y, Epstein SF, Cuddy M, Slabiak T, Nowell PC, Croce CM: Regulation of Bcl-2 gene expression in lymphoid cell lines containing normal #18 or t(14:18) chromosomes. Oncogene Res 4:271, 1989
12. Young RL, Korsmeyer SJ: A negative regulatory element in the bcl-2 5′-untranslated region inhibits expression from an upstream promoter. Mol Cell Biol 13:3686, 1993
13. Shtivelman E, Lifshitz B, Gale RP, Roe BA, Canaani E: Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell 47:277, 1986
14. Pandolfi PP, Alcalay M, Fagioli M, Zangrilli D, Mencarelli A, Diverio D, Biondi A, Lo Coco F, Rambaldi A, Grignani F, Rochette-Egly C, Gaube M-P, Chambon P, Pelicci PG: Genomic variability and alternative splicing generate multiple PML-RARα transcripts that encode aberrant PML proteins and PML-RARα isoforms in acute promyelocytic leukaemia. EMBO J 11:1397, 1992
15. von Lindern M, Breems D, van Baal S, Adriaansen H, Grosveld G: Characterization of the translocation breakpoint sequences of two DEK-CAN fusion genes present in t(6;9) acute myeloid leukemia and a SET-CAN fusion gene found in a case of acute undifferentiated leukemia. Genes Chromosom Cancer 5:227, 1992
16. Neri A, Chang CC, Lombardi L, Salina M, Corradini P, Maiolo AT, Chaganti RS, Dalla-Favera R: B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. Cell 67:1075, 1991
17. Domer PH, Fakharzadeh SS, Chein-Shing C, Jockel J, Johansen L, Silverman GA, Kersey JH, Korsmeyer SJ: Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc Natl Acad Sci USA 90:7884, 1993
18. Mason, JO, Williams GT, Neuberger MS: The half-life of immunoglobulin mRNA increases during B-cell differentiation: A possible role for targeting to membrane-bound polysomes. Genes Dev 2:1003, 1988
19. Jaeck H-M, Wabl M: Immunoglobulin mRNA stability varies during B lymphocyte differentiation. EMBO J 7:1041, 1988
20. Left SE, Evans RM, Rosenfeld MG: Splice commitment dictates neuron-specific alternative RNA processing in calcitonin/CGRP gene expression. Cell 48:517, 1987
21. Streuli M, Saito H: Regulation of tissue-specific alternative splicing: Exon-specific cis-elements govern the splicing of leukocyte common antigen pre-mRNA. EMBO J 8:787, 1989
22. Engebrecht J, Voelkel-Meiman K, Roeder GS: Meiosis-specific RNA splicing in yeast. Cell 66:1257, 1991
23. Felber BK, Hadzopoulou-Cladaras M, Cladaras C, Copeland T, Pavlakis GN: REV protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc Natl Acad Sci USA 86:1495, 1989
24. Tabernero C, Zolotukhin AS, Valentin A, Pavlakis GN, Felber BK: The posttranscriptional control element of the simian retrovirus type 1 forms an extensive RNA secondary structure necessary for its function. J Viral 70:5998, 1996
25. Watanabe CT, Rosenblatt JD, Bakker A, Morgan JP, Luo J, Chun S, Black AC: Negative regulation of gene expression from the HTLV type II long terminal repeat by rex: Functional and structural dissociation from positive posttranscriptional regulation. AIDS Res Hum Retroviruses 12:535, 1996
26. Alonso-Caplen FV, Kmug RM: Regulation of the extent of splicing of influenza virus NS1 mRNA: Role of the rates of splicing and of the nucleocytoplasmic transport of NSI mRNA. Mol Cell Biol 11:1092, 1991
27. Huang ZM, Zang WQ, Yen B: Cellular proteins that bind to the hepatitis B virus posttranscriptional regulatory element. Virology 217:573, 1996
28. Donello JE, Beeche AA, Smith GJ III, Lucero GR, Hope TJ: The hepatitis B virus posttranscriptional regulatory element is composed of two subelements. J Virol 70:4345, 1996
29. Grosschedl R, Baltimore D: Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements. Cell 41:885, 1985
30. Minowada J: Immunology of leukemic cells, in Gunz F, Henderson E (eds): Leukemia. New York, NY, Grune & Stratton, 1982, p 119
31. Winter JN, Variakojis D, Epstein AL: Phenotypic analysis of established diffuse histiocytic lymphoma cell lines utilizing monoclonal and cytochemical techniques. Blood 63:140, 1984
32. Paige CJ, Schreier MH, Seidman CL: Mediators from cloned T helper cell lines affect immunoglobulin expression by B cells. Proc Natl Acad Sci USA 79:4756, 1982
33. Ng S-Y, Gunning P, Eddy R, Ponte P, Leavitt J, Shows T, Kedes L: Evolution of the functional human β-actin gene and its multipseudogene family: Conservation of noncoding regions and chromosomal dispersion of pseudogenes. Mol Cell Biol 5:2720, 1985
34. Gunning P, Leavitt J, Muscat G, Ng S-Y, Kedes L: A human β-actin expression vector system directs high-level accumulation of antisense transcripts. Proc Natl Acad Sci USA 84:4831, 1987
35. Frederickson RM, Micheau MR, Iwamoto A, Miyamoto NG: 5′flanking and first intron sequences of the human β-actin gene required for efficient promoter activity. Nucleic Acids Res 17:253, 1989
36. Chu G, Hayakawa H, Berg P: Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acids Res 15:1311, 1987
37. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning, A Laboratory Manual (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989, p 7.5
38. Chirgwin JM, Przbyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294, 1979
39. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
40. Ponte P, Ng S-Y, Engel J, Gunning P, Kedes L: Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human β-actin cDNA. Nucleic Acids Res 12:1687, 1984
41. Hohn PA, Popescu NC, Hanson RD, Salvesen G, Ley TJ: Genomic organization and chromosomal localization of the human cathepsin G gene. J Biol Chem 264:13412, 1989
42. Yang JQ, Bauer S, Mushinski JF, Marcu KB: Chromosome translocations clustered 5′ of the murine C-MYC gene qualitatively affect promoter usage: Implications for the site of normal C-MYC regulation. EMBO J 4:1441, 1985
43. Eick D, Bornkamm GW: Transcriptional arrest within the first exon is a fast control mechanism in C-MYC gene expression. Nucleic Acids Res 14:8331, 1986
44. Kjems J, Frankel AD, Sharp P: Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 REV. Cell 67:169, 1991
45. Inoue J-I, Itoh M, Akizawa T, Toyoshima H, Yoshida M: HTLV-I Rex protein accumulates unspliced RNA in the nucleus as well as in cytoplasm. Oncogene 6:1753. 1991
46. Palmeri D, Malim MH: The human T-cell leukemia virus type 1 posttranscriptional trans-activator rex contains a nuclear export signal. J Virol 70:6442, 1996
47. Hyde-DeRuyscher R, Carmichael GG: Polyomavirus early-late switch is not regulated at the level of transcription initiation and is associated with changes in RNA processing. Proc Natl Acad Sci USA 85:8993, 1988
48. Caffarelli E, Fragapane P, Gehring C, Bozzoni I: The accumulation of mature RNA for the Xenopus laevis ribosomal protein L1 is controlled at the level of splicing and turnover of the precursor RNA. EMBO J 6:3493, 1987
49. Ley TJ, Connolly NL, Katamine S, Cheah MSC, Senior RM, Robbins KC: Tissue-specific expression and developmental regulation of the human FGR proto-oncogene. Mol Cell Biol 9:92, 1989
50. Pilder S, Moore M, Logan J, Shenk T: The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol Cell Biol 6:470, 1986
51. Leppard KN, Shenk T: The adenovirus E1B 55kd protein influences mRNA transport via an intranuclear effect on RNA metabolism. EMBO J 8:2329, 1989
52. Martin K, Helenius A: Nuclear transport of influenza virus ribonucleoproteins: The viral matrix protein (M1) promotes export and inhibits import. Cell 67:117, 1991
53. Villareal LP, White T: A splice site junction deletion deficient in the transport of RNA does not polyadenylate nuclear RNA. Mol Cell Biol 3:1381, 1983
54. Zeitlin S, Parent A, Silverstein S, Efstratiadis A: Pre-mRNA splicing and the nuclear matrix. Mol Cell Biol 7: 111, 1987
55. Schroeder HC, Bachmann M, Diehl-Seifert B, Mueller WEG: Transport of mRNA from nucleus to cytoplasm. Prog Nucleic Acid Res Mol Biol 34:89, 1987
56. Huang, S, Spector DL: Nascent pre-mRNA transcripts are associated with nuclear regions enriched in splicing factors. Genes Dev 5:2288, 1991
57. Hochstrasser M, Sedat JW: Three-dimensional organization of Drosophila melanogaster interphase nuclei. I. Tissue-specific aspects of polytene nuclear architecture. J Cell Biol 104:1455, 1987
58. Cremer T, Cremer C, Baumann H, Luedtke E-K, Sperling K, Teuber V, Zorn C: Rabl's model of the interphase chromosome arrangement tested in Chinese hamster cells by premature chromosome condensation and laser-UV-microbeam experiments. Hum Genet 60:46, 1982
59. Adami G, Babiss LE: DNA template effect on RNA splicing: Two copies of the same gene in the same nucleus are processed differently. EMBO J 10:3457, 1991
60. Peterson ML, Perry R: The regulated production of um and us m RNA is dependent on the relative efficiencies of us poly(A) site usage and the Cμ4-to-M1 splice. Mol Cell Biol 9:726, 1989
61. Virtanen A, Sharp PA: Processing at immunoglobulin polyadenylation sites in lymphoid cell extracts. EMBO J 7:1421, 1988
62. Milcarek C, Suda-Hartman M, Croll SC: Changes in abundance of IgG 2a mRNA in the nucleus and cytoplasm of a murine B-lymphoma before and after fusion to a myeloma cell. Mol Immunol 33:691, 1996
63. Gram H, Zenke G, Geisse S, Kleuser B, Bürki K: High level expression of a human immunoglobulin γ1 transgene depends on switch region sequences. Eur J Immunol 22:1185, 1992
64. Watakabe A, Tanaka K, Shimura Y: The role of exon sequences in splice site selection. Genes Dev 7:407, 1993
65. Gruss P, Khoury G: Rescue of a defective mutant by insertion of an heterologous intron. Nature 286:634, 1980
66. Neuberger MS, Williams GT: The intron requirement for immunoglobulin gene expression is dependent upon the promoter. Nucleic Acids Res 16:6713, 1988
67. Nesic D, Marquat LE: Upstream introns influence the efficiency of final intron removal and RNA 3′-end formation. Genes Dev 8:363, 1994
68. Ghia P, Boekel ET, Sanz E, Hera ADL, Rolink A, Melchers F: Ordering of human bone marrow B lymphocyte precursors by singlecell polymerase chain reaction analyses of the rearrangement status of the immunoglobulin H and L chain gene loci. J Exp Med 184:2217, 1996